Genosensör ile yeni bir girişimsel olmayan doğum öncesi tanı yöntemi

Year 2021, Volume: 46 Issue: 1, 208 - 215, 31.03.2021

Umut Kökbaş Levent Kayrın Abdullah Tuli

Abstract

Amaç: Bu çalışmanın amacı, maternal kandaki “cell-free” fetal DNA'dan paternal mutasyon tayini için nanopolimer bazlı genosensör ile yeni bir prosedür geliştirmektir.
Gereç ve Yöntem: Kuvars-kristal mikrobalans (QCM) ve biyosensör teknolojilerini kullanılarak β-talasemi IVS1-110 mutasyonun analizine uygulanmıştır. Bu amaçla, mutasyona ait problar genosensör elektrodu üzerine PoliHema-MAC nanopolimeri aracılığıyla bağlandı ve daha sonra örnekler tespit amacıyla çalışma hücresine eklendi. Genosensörün optimizasyon, karakterizasyon, duyarlılık ve özgüllük çalışmaları yapıldı.
Bulgular: Biyosensör ölçümleri -0,6 - 0,8 V sabit akım aralığında döngüsel volatmetriyle elde edildi. Girişimsel olmayan doğum öncesi tanı testi yapılan fetüslerde ARMS yöntemiyle ortak sonuçlar elde edilmiştir. ARMS sonuçları genosensör sonuçları ile istatistiksel olarak karşılaştırıldığında çizilen ROC eğrisinde %99 uyumluluk oranı elde edilmiştir.
Sonuç: Geliştirilen biyosensör, yüzeyinde bulunan proba özgül olarak, fetüsün paternal mutasyonunun varlığını ortaya koyabilmektedir. Rutinde kullanılan geleneksel yöntemlerle karşılaştırıldığında, daha düşük maliyetli, hızlı sonuç verebilen, özgüllüğü ve saptama etkinliği yüksek olarak bulunmuştur.

Keywords

Genosensör, “Cell-Free” Fetal DNA, Nanopolimer

Supporting Institution

Çukurova Üniversitesi Bilimsel Araştırma Projeleri Birimi

Project Number

TDK-2017-8841

Thanks

Çukurova Üniversitesi Bilimsel Araştırma Projeleri Birimi'ne çalışmamızı desteklediği için teşekkür ederiz.

A novel non-invasive prenatal test technique with genosensor

Abstract

Purpose: The aim of this study is to develop a new procedure with nanopolymer based genosensor for the determination of paternal mutation from cell-free fetal DNA in maternal blood.
Materials and Methods: β-thalassemia IVS1-110 mutation analysis was performed using quartz-crystal microbalance (QCM) and biosensor technologies. For this purpose, the probes of the mutation were immobilized on the genosensor electrode surface by means of Poly Hema-MAC nanopolymer and then samples were added to the working cell for detection. Optimization, characterization, sensitivity and specificity studies of the genosensor were performed.
Results: Biosensor measurements were obtained between -0.6 and 0.8 V in a constant current range by cyclic voltammetry. Common results were obtained with ARMS method in fetuses who had non-invasive prenatal diagnosis tests. When the ARMS results were compared with the genosensor results statistically, a 99% concordance rate was obtained in the ROC curve drawn.
Conclusions: The developed biosensor can detect the presence of paternal mutation of the fetüs specific to the probe on its surface. Compared with the traditional methods used in routine, it was found to be more cost-effective, faster, with high specificity and detection efficiency.

Keywords

Genosensor, Cell-FreeFetal DNA, Nanopolymer

Project Number

TDK-2017-8841

References

• Beattie KL, Beattie WG, Meng L, et al. Advances in genosensor research. Clin Chem.1995;41(5):700-706.
• Sabahi A, Salahandish R, Ghaffarinejad A, Omidinia E. Electrochemical nano-genosensor for highly sensitive detection of miR-21 biomarker based on SWCNT-grafted dendritic Au nanostructure for early detection of prostate cancer. Talanta.2020;209:120595.
• Daneshpour M, Moradi LS, Izadi P, Omidfar K. Femtomolar level detection of RASSF1A tumor suppressor gene methylation by electrochemical nano-genosensor based on Fe3O4/TMC/Au nanocomposite and PT-modified electrode. Biosens Bioelectron.2016;77:1095-1103.
• Kokbas U, Kayrin L, Tuli A. Lab-on-a-chip based biosensor for the real-time multiplex analysis of alpha thalassemia mutations from cell-free DNA. Febs Open Bio.2019;9:374-374.
• Semsi R, Kokbas U, Arslan B, Dincel AS, Ergunol E, Kayrin L. Comparison of chemiluminescence immunoassay and biosensor methods for measurement of saliva glucose levels in adults. Febs Open Bio.2019;9:129-129.
• Fernandes AM, Abdalhai MH, Ji J, et al. Development of highly sensitive electrochemical genosensor based on multiwalled carbon nanotubes-chitosan-bismuth and lead sulfide nanoparticles for the detection of pathogenic Aeromonas. Biosens Bioelectron.2015;63:399-406.
• Malecka K, Swieton E, Verwilst P, et al. Ultrasensitive electrochemical genosensor for direct detection of specific RNA sequences derived from avian influenza viruses present in biological samples. Acta Biochim Pol.2019;66(3):299-304.
• Kanwal S, Bukhari S, Perveen S. Molecular genetics and prenatal diagnosis of beta thalassemia to control transfusion dependent births in carrier Pakistani couples. J Pak Med Assoc.2017;67(7):1030-1034.
• Fortunati S, Rozzi A, Curti F, Giannetto M, Corradini R, Careri M. Novel amperometric genosensor based on peptide nucleic acid (PNA) probes immobilized on carbon nanotubes-screen printed electrodes for the determination of trace levels of non-amplified DNA in genetically modified (GM) soy. Biosens Bioelectron.2019;129:7-14.
• Yenilmez ED, Kokbas U, Kartlasmis K, Kayrin L, Tuli A. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women. Plos One.2018;13(6).
• Fries N, Le Garrec S, Egloff M, et al. Non-invasive prenatal testing: what are we missing? Ultrasound Obstet Gynecol.2020.
• Park AL, Huang T, Meschino WS, Iqbal J, Ray JG. Prenatal Biochemical Screening and a Woman's Long-Term Risk of Cancer: A Population-Based Cohort Study. JNCI Cancer Spectr.2020;4(1):pkz077.
• van Campen J, Silcock L, Yau S, et al. A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies. Br J Haematol.2020.
• Alparslan MM, Yenilmez ED, Sanna B, Kokbas U, Tuli A. Alpha/Beta globin mRNA ratio informs the gene function for personalized mutation data in molecular screening of thalasemia carriers. Febs J.2016;283:182-183.
• Zafari M, Kosaryan M, Gill P, et al. Non-invasive prenatal diagnosis of beta-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis. Ann Hematol.2016;95(8):1341-1350.
• Farzin L, Sadjadi S, Shamsipur M, Sheibani S. Electrochemical genosensor based on carbon nanotube/amine-ionic liquid functionalized reduced graphene oxide nanoplatform for detection of human papillomavirus (HPV16)-related head and neck cancer. J Pharm Biomed Anal.2020;179:112989.
• Ye Y, Mao S, He S, et al. Ultrasensitive electrochemical genosensor for detection of CaMV35S gene with Fe3O4-Au@Ag nanoprobe. Talanta.2020;206:120205.
• Lv W, Linpeng S, Li Z, et al. Non-invasive prenatal diagnosis for pregnancies at risk for beta-thalassemia: a retrospective study. BJOG.2020.
• Liang D, Lin Y, Li H, Hu P, Xu ZF. [Analysis of follow-up information and pregnancy outcomes of cell free DNA prenatal screening]. Zhonghua Fu Chan Ke Za Zhi.2020;55(2):106-111.
• Wong P, Suannum P, Jermnim S, et al. Lessons learned from a prenatal diagnosis program for thalassemia in Thailand. Prenat Diagn.2020.
• Tang J, Zhou C, Shi H, et al. Prenatal diagnosis of skeletal dysplasias using whole exome sequencing in China. Clin Chim Acta.2020.
• Togneri FS, Kilby MD, Young E, et al. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory. Genet Res (Camb).2019;101:e11.
• Wang Y, Li S, Wang W, et al. Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma. Mol Cytogenet.2020;13:10.
• Chen PQ, Liang QN, Huang TS, Liu TC, Li M. A Simple, Rapid, and Highly Sensitive Electrochemical DNA Sensor for the Detection of alpha- and beta-Thalassemia in China. J Clin Lab Anal.2016;30(5):719-726.
• Chomean S, Potipitak T, Promptmas C, Ittarat W. Quartz crystal microbalance-based biosensor for the detection of alpha-thalassemia 1 (SEA deletion). Clin Chem Lab Med.2010;48(9):1247-1254.
• Chau MHK, Lam YMD, Zhu X, et al. The utility of genome-wide cell-free DNA screening in the prenatal diagnosis of Pallister-Killian syndrome. Prenat Diagn.2020.
• Feriotto G, Breveglieri G, Gardenghi S, Carandina G, Gambari R. Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of beta o 39 thalassemia mutation. Mol Diagn.2004;8(1):33-41.
• Wangmaung N, Promptmas C, Chomean S, Sanchomphu C, Ittarat W. Low cost biosensor-based molecular differential diagnosis of alpha-thalassemia (Southeast Asia deletion). Clin Chem Lab Med.2013;51(6):1199-1205.
• Hussain KK, Gurudatt NG, Akhtar MH, Seo KD, Park DS, Shim YB. Nano-biosensor for the in vitro lactate detection using bi-functionalized conducting polymer/N, S-doped carbon; the effect of alphaCHC inhibitor on lactate level in cancer cell lines. Biosens Bioelectron.2020;155:112094.
• Liu F, Lin Z, Jin Q, et al. Protection of Nanostructures-Integrated Microneedle Biosensor Using Dissolvable Polymer Coating. ACS Appl Mater Interfaces.2019;11(5):4809-4819.
• Zhang P, Sun T, Rong S, et al. A sensitive amperometric AChE-biosensor for organophosphate pesticides detection based on conjugated polymer and Ag-rGO-NH2 nanocomposite. Bioelectrochemistry.2019;127:163-170.